MOTS-c
Also known as: Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c is a popular peptide topic online, but it is not FDA-approved for human use. Use this guide to understand the claims, the evidence gaps, and the safety questions to ask before considering anything further.
Exciting early-stage research. Human clinical trials underway at USC. Animal data shows insulin sensitization, fat loss, and longevity effects. Human data emerging.
What to know before you go deeper
Mitochondria-encoded peptide that regulates metabolism, insulin sensitivity, and exercise capacity. Acts similarly to exercise at the cellular level — hence called an "exercise mimetic."
Approval status: Not FDA-approved. This is not an FDA-approved human treatment.
Metabolic health and insulin sensitivity, Exercise performance and endurance, Longevity and healthspan.
What evidence applies to my situation, what monitoring is needed, and what safer first steps should I try?
Why People Ask About MOTS-c
- Metabolic health and insulin sensitivity
- Exercise performance and endurance
- Longevity and healthspan
- Obesity management
Questions to Bring Up
Early research topic only. Human use should not be self-directed outside appropriate clinical oversight or trials.
Dosing, sourcing, and suitability questions belong with a licensed clinician who can review your history, labs, medications, and goals.
Known Side Effects
- Unknown in humans — insufficient data
- Generally well-tolerated in animal studies
Important Safety Notes
⚠ Research use only — very early stage
Levels naturally decline with age — therapeutic rationale is restoration
Exercise is the best-studied way to raise MOTS-c naturally
What Is Approved?
Mitochondria-derived peptide. Research only — no approved formulation. Discovered relatively recently (2015) with rapidly growing interest.
Your feedback helps us improve the guide.